Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1891)	1/22/2008 11:27:15 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

GNVC Also has recovered from its earlier dip & is now up 6.21% with volume < half its ADV. stockcharts.com It announced on Friday the appointment of Kevin Rooney to its board, who is currently the president of Beacon Consulting Group, Which provides consulting services to biopharmaceutical executives. He was a V.P. for MedImmune's oncology division. GNVC needs to close above the $1.70 level. Its short ratio came down 15% but is still > 8x its ADV. Bernard